The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Davita Inc.  (DVA) Trade Now »     Rate DVA  -  Discuss DVA  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Healthcare Facilities
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
100.0%
Top:
100.0%
Rate DVA:



DVA Analysis & Videos »


DVA: Bull or Bear?

Rockwell Medical: Improving Margins, SFP Key to Future Graphic_rating_buy DVA
Mikerun
73%
 +13.77%
in 106 days
By Mike Havrilla on 3/25/09 at BioMedReports.com
 
<> In mid-March, Rockwell Medical Technologies (RMTI) reported 4Q and FY08 results which included revenue of $13.5M (up 13.3% from year-ago quarter) and $51.6M (up 20% compared to 2007). The net losses were ($3M) and ($7.9M) for 4Q and FY08, respectively. Despite solid sales growth, RMTI has posted losses as margins have suffered due to higher raw material/fuel costs and other investments in personnel, information technology (IT), and clinical development...
By  Mike Havrilla   (+1.04%  risk: conservative)  03/25/09 Comment


A New Global Healthcare Composite Index Graphic_rating_buy DVA
Mikerun
73%
 -1.59%
in 121 days
(closed on 03/25/09)

A New Global Healthcare Composite Index

<>

The accompanying table [click to enlarge or download] presents the top five rated companies with market caps of at least $250M from each of the 10 new healthcare indexes developed by ETF Innovators [ETFI] from a database of about 500 companies worldwide. The ETFI Global Healthcare Sector PerformIdex consists of 50 top rated companies on an equal weight basis from each of the 10 new healthcare indexes as an alternative strategy to existing health composite ETFs with highly correlated returns and over-weight exposure to th...
By  Mike Havrilla   (+1.04%  risk: conservative)  11/23/08 Comment


Hospitals Hoping for Increased Insurance Coverage Graphic_rating_buy DVA
Mikerun
73%
 -14.35%
in 15 days
(closed on 11/23/08)

Hospitals Hoping for Increased Insurance Coverage

<>

The combination of a bad economy and rising unemployment is contributing to unpaid bills and operating losses at U.S hospital companies such as Tenet Healthcare (THC), which missed analyst estimates last week by 3-cents with an adjusted 6-cent per share loss and lowered its full-year and 2009 guidance for EBITDA. Tenet's allowance for doubtful accounts increased 5.8% to $163M at hospitals run by the Company for over a year.

With Tenet trading all-time lows, several insiders were buying a combined 160...
By  Mike Havrilla   (+1.04%  risk: conservative)  11/08/08 Comment


Get free stock alert for DVA:
Your Email Address:


Cramer on BloggingStocks: Genentech bid confirms the trend Graphic_rating_buy DVA
-4.28%
in 352 days

Filed under: Deals, Market matters, Anheuser-Busch Cos (BUD), Research in Motion (RIMM), Genentech Inc (DNA), Amgen Inc (AMGN), Gilead Sciences (GILD), Stocks to Buy, Cramer on BloggingStocks

TheStreet.com's Jim Cramer says the biotechs look sweet in a bank-led slowdown.

Thank you, New York Times. Remember just a couple of weeks ago, when The New York Times wrote about how Genentech's (NYSE: DNA) (Cramer's Take) Avastin was too expensive and the stock got cracked down to $77? I know Roche did. I bet that was the last draw. The dramatic decline in the dollar plus a sentiment that has spawn...
By  Jim Cramer   (-10.04%  risk: moderate)  07/21/08 Comment


DVA: Davita Looks Healthy Graphic_rating_buy DVA
Billtrent
13%
 -4.28%
in 356 days

My latest column is up at RealMoney.

DaVita (DVA) is a leading provider of dialysis services in the U.S. for patients suffering from chronic kidney failure, also known as end-stage renal disease, or ESRD. As of Dec. 31, 2007, the company operated or provided administrative services to 1,359 outpatient dialysis centers serving about 107,000 patients.

The total ESRD market is estimated at 340,000 patients and is growing 3% to 4% annually. DaVita and its largest competitor, Fresnius Medical Care (FMS) , together control 65% of the dialysis market.

<>Over the last 12 months, DaVita’s <>free ca...
By  Stock Market Beat   (-20.89%  risk: aggressive)  07/17/08 Comment


Bullish on DVA ... Graphic_rating_buy DVA
888
 6 %
 -10.10%
in 876 days
<>DaVita, Inc. provides dialysis services in the United States for patients suffering from chronic kidney failure, which is also known as end stage renal disease (ESRD). The company operates kidney dialysis centers, and provides related medical services primarily in dialysis centers and in contracted hospitals. Its services include outpatient dialysis services; hospital inpatient dialysis services; and ancillary services, such as ESRD laboratory services, vascular access services, and disease management services. In addition, the company conducts research trials of new pharmaceuticals and med...
By  gglquick   (-58.97%  risk: aggressive)  02/13/07 Comment





People Bullish on DVA

Mikerun
Mike Havrilla
Principal
73%
3 mos ago

Statistician
Analyst
N/A
7 mos ago

Art
Analyst
N/A
7 mos ago

Mobile_avatar
flagman1
Analyst
73%
8 mos ago

mhauptm4
Analyst
37%
10 mos ago


People Bearish on DVA

ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +42.42% 274
2 Gerald Greene 18.14 +54.81% 140
3 stockmarketfunding.com 17.66 +22.12% 35
4 akiralegrand 13.47 +15.91% 49
5 anup2104 12.13 +34.41% 13


POPULAR STOCKS
Symbol Company Name Sentiment
MA MasterCard Inc
YHOO Yahoo! Inc
WFC Wells Fargo & Company
RIMM Research in Motion Ltd
MO Altria Group Inc
DELL Dell Inc

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on DVA


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About Davita Inc. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch